FI862674A - Cdna-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-vaextfaktoraktivitet. - Google Patents

Cdna-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-vaextfaktoraktivitet. Download PDF

Info

Publication number
FI862674A
FI862674A FI862674A FI862674A FI862674A FI 862674 A FI862674 A FI 862674A FI 862674 A FI862674 A FI 862674A FI 862674 A FI862674 A FI 862674A FI 862674 A FI862674 A FI 862674A
Authority
FI
Finland
Prior art keywords
cdna
som
vaextfactoractives
granulosytmacrofag
eosinofil
Prior art date
Application number
FI862674A
Other languages
English (en)
Other versions
FI103986B (fi
FI862674A0 (fi
FI103986B1 (fi
Inventor
Takasi Yokota
Frank Don Lee
Donna Maye Rennick
Ken-Ichi Arai
Original Assignee
Schering Biotech Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Biotech Corp filed Critical Schering Biotech Corp
Publication of FI862674A publication Critical patent/FI862674A/fi
Publication of FI862674A0 publication Critical patent/FI862674A0/fi
Application granted granted Critical
Publication of FI103986B publication Critical patent/FI103986B/fi
Publication of FI103986B1 publication Critical patent/FI103986B1/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/53Colony-stimulating factor [CSF]
    • C07K14/535Granulocyte CSF; Granulocyte-macrophage CSF
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/02Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
FI862674A 1984-11-20 1986-06-24 cDNA-kloonit, jotka koodaavat polypeptidejä, joilla on humaani sellulaarinen granulosyyttimakrofaagi- ja eosinofiili-kasvutekijäaktiivisuus FI103986B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US67389884A 1984-11-20 1984-11-20
US67389884 1984-11-20
US8502250 1985-11-18
PCT/US1985/002250 WO1986003225A1 (en) 1984-11-20 1985-11-18 cDNA CLONES CODING FOR POLYPEPTIDES EXHIBITING HUMAN GRANULOCYTE MACROPHAGE AND EOSINOPHIL CELLULAR GROWTH FACTOR ACTIVITY

Publications (4)

Publication Number Publication Date
FI862674A true FI862674A (fi) 1986-06-24
FI862674A0 FI862674A0 (fi) 1986-06-24
FI103986B FI103986B (fi) 1999-10-29
FI103986B1 FI103986B1 (fi) 1999-10-29

Family

ID=24704538

Family Applications (1)

Application Number Title Priority Date Filing Date
FI862674A FI103986B1 (fi) 1984-11-20 1986-06-24 cDNA-kloonit, jotka koodaavat polypeptidejä, joilla on humaani sellulaarinen granulosyyttimakrofaagi- ja eosinofiili-kasvutekijäaktiivisuus

Country Status (26)

Country Link
EP (1) EP0202300B1 (fi)
JP (1) JP3038348B2 (fi)
KR (1) KR920003822B1 (fi)
CN (3) CN1031465C (fi)
AT (1) ATE82321T1 (fi)
AU (1) AU608741B2 (fi)
BG (1) BG60840B2 (fi)
DE (1) DE3586826T2 (fi)
DK (1) DK174598B1 (fi)
ES (1) ES8705470A1 (fi)
FI (1) FI103986B1 (fi)
GR (1) GR852786B (fi)
HK (1) HK6096A (fi)
HU (1) HU213226B (fi)
IE (1) IE59581B1 (fi)
IL (1) IL77080A (fi)
LU (1) LU88360I2 (fi)
MX (1) MX9203397A (fi)
MY (1) MY101971A (fi)
NL (1) NL930120I2 (fi)
NO (1) NO862903L (fi)
NZ (1) NZ214225A (fi)
OA (1) OA08671A (fi)
PT (1) PT81513B (fi)
WO (1) WO1986003225A1 (fi)
ZA (1) ZA858833B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
UA29377C2 (uk) * 1984-09-19 2000-11-15 Новартіс Аг Спосіб отримання білка з активністю колонієстимулювального фактора гранулоцитів та макрофагів(gm-csf) приматів
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
US5078996A (en) * 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
WO1987002060A1 (en) * 1985-10-03 1987-04-09 Biogen N.V. Human granulocyte-macrophage colony stimulating factor-like polypeptides and processes for producing them in high yields in microbial cells
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
US5298603A (en) * 1985-12-21 1994-03-29 Hoechst Aktiengesellschaft GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
DE3545568A1 (de) * 1985-12-21 1987-07-16 Hoechst Ag Gm-csf-protein, seine derivate, herstellung solcher proteine und ihre verwendung
JP2583770B2 (ja) * 1986-09-17 1997-02-19 大塚製薬株式会社 遺伝子
EP0276846A3 (en) * 1987-01-29 1989-07-26 Zymogenetics, Inc. Colony-stimulating factor derivatives
JPS6420097A (en) * 1987-03-02 1989-01-24 Sumitomo Chemical Co Human granulocyte-macrophage colony stimulating factor
AU621051B2 (en) * 1987-04-28 1992-03-05 Amgen, Inc. Method for purifying granulocyte-macrophage colony stimulating factor
IE63514B1 (en) * 1987-07-17 1995-05-03 Schering Biotech Corp Expression vectors for the production of human granulocyte-macrophage colony stimulation factor in a mammalian cell host
AU626530B2 (en) * 1987-07-17 1992-08-06 Schering Biotech Corporation Human granulocyte-macrophage colony stimulating factor and muteins thereof
GB2212159B (en) * 1987-11-13 1992-01-22 British Bio Technology Synthetic gene for human granulocyte/macrophage colony stimulating factor.
JPH03503897A (ja) * 1988-04-21 1991-08-29 メドベット・サイエンス・プロプライアテリー・リミテッド ひとgm‐csf変異形類
US5109119A (en) * 1989-06-06 1992-04-28 Schering Corporation Crystalline r-h-gm-csf and method
KR100448021B1 (ko) * 2001-12-28 2004-09-08 크레아젠 주식회사 마우스 과립구 대식세포 콜로니 촉진인자 발현벡터 pGM-CSF로 형질전환된 대장균 및 상기 마우스 과립구 대식세포 콜로니 촉진인자의 대량생산방법
CA2497554A1 (en) * 2002-09-20 2004-04-01 Dendreon Corporation Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438032A (en) * 1981-01-30 1984-03-20 The Regents Of The University Of California Unique T-lymphocyte line and products derived therefrom
AU594014B2 (en) * 1984-03-21 1990-03-01 Research Corporation Technologies, Inc. Recombinant DNA molecules
AU599572B2 (en) * 1984-07-06 1990-07-26 Novartis Ag Lymphokine production and purification
ZA856108B (en) * 1984-10-29 1986-10-29 Immunex Corp Cloning of human granulocyte-macrophage colony simulating factor gene
AU588819B2 (en) * 1984-10-29 1989-09-28 Immunex Corporation Cloning of human granulocyte-macrophage colony stimulating factor gene

Also Published As

Publication number Publication date
MX9203397A (es) 1992-07-01
OA08671A (en) 1989-03-31
JPS62501259A (ja) 1987-05-21
CN1045539C (zh) 1999-10-13
NL930120I1 (nl) 1993-11-01
JP3038348B2 (ja) 2000-05-08
NO862903L (no) 1986-09-18
IE852889L (en) 1986-05-20
IE59581B1 (en) 1994-03-09
CN1086543A (zh) 1994-05-11
FI103986B (fi) 1999-10-29
BG60840B2 (bg) 1996-04-30
PT81513A (en) 1985-12-01
DK174598B1 (da) 2003-07-14
DE3586826T2 (de) 1993-03-25
IL77080A0 (en) 1986-04-29
ES8705470A1 (es) 1987-05-01
NL930120I2 (nl) 1994-07-01
ES548998A0 (es) 1987-05-01
CN1020473C (zh) 1993-05-05
NO862903D0 (no) 1986-07-18
AU608741B2 (en) 1991-04-18
CN85109132A (zh) 1986-12-03
DK345286D0 (da) 1986-07-21
LU88360I2 (fr) 1994-05-04
IL77080A (en) 1998-02-08
FI862674A0 (fi) 1986-06-24
HK6096A (en) 1996-01-19
HUT40464A (en) 1986-12-28
FI103986B1 (fi) 1999-10-29
NZ214225A (en) 1991-05-28
DK345286A (da) 1986-07-21
ZA858833B (en) 1986-06-25
DE3586826D1 (de) 1992-12-17
ATE82321T1 (de) 1992-11-15
GR852786B (fi) 1986-03-20
CN1031465C (zh) 1996-04-03
HU213226B (en) 1997-03-28
AU5196386A (en) 1986-06-18
EP0202300A1 (en) 1986-11-26
PT81513B (pt) 1988-03-03
KR920003822B1 (ko) 1992-05-15
KR860700359A (ko) 1986-10-06
EP0202300B1 (en) 1992-11-11
MY101971A (en) 1992-02-29
WO1986003225A1 (en) 1986-06-05

Similar Documents

Publication Publication Date Title
FI862674A (fi) Cdna-kloner, som kodar polypeptider, som har human sellularisk granulosytmakrofag- och eosinofil-vaextfaktoraktivitet.
GR80517B (en) Cdna clones coding for polypeptides exhibiting multi-lineage cellular growth factor activity
DE3280471D1 (de) Mikrobisch-produziertes Rinderwachstumshormon und dessen Verwendung.
GEP19970775B (en) Method for the production of human erythropoietin
DE3880468D1 (de) Rekombinante dns-expressionsvektoren.
KR920702417A (ko) Tcf-ii의 아미노산 배열을 코드하는 dna를 함유한 플라스미드, 형질전환세포, 및 이것을 사용하여 생리 활성물질을 생산하는 방법
ATE175719T1 (de) Epididymis-spezifische polypeptide und deren verwendung
ES8607392A1 (es) Un procedimiento para producir un polipeptido que exhibe ac-tividad de factor de fijacion de ige de mamifero
MX9707244A (es) Expresion de genes en celulas de mamifero.

Legal Events

Date Code Title Description
SPCG Supplementary protection certificate granted

Spc suppl protection certif: L165

Extension date: 20061107

FG Patent granted

Owner name: SCHERING BIOTECH CORPORATION

MA Patent expired